Apical Ballooning Syndrome Clinical Trial
Official title:
Personality Profile of Patients With Apical Ballooning Syndrome (ABS)
| Verified date | February 2015 |
| Source | Mayo Clinic |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Observational |
The investigators' hypothesis is that patients with apical ballooning syndrome (ABS) will manifest a personality profile that differs than that of a population of similar range of ethnic and socioeconomic status.
| Status | Completed |
| Enrollment | 53 |
| Est. completion date | September 2014 |
| Est. primary completion date | September 2014 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion criteria: 1. Patients who have suffered with ABS 2. Adults (18 years or older) 3. Able to read English at a 6th grade level (questionnaires are self-administered and written in English) Exclusion criteria: 1. Have withdrawn from the registry 2. Have died |
Observational Model: Case-Only, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| United States | Mayo Clinic in Rochester | Rochester | Minnesota |
| Lead Sponsor | Collaborator |
|---|---|
| Mayo Clinic |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Range of personality traits as assessed by the "NEO-PI-3" | The "NEO PI-3" measures the five major domains of personality, which are: Neuroticism Extraversion Openness Agreeableness Conscientiousness |
Baseline: the traits will be assessed once upon enrollment into the study | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00975559 -
The Relationship Between the Response to Mental Stress and Vascular Endothelial Function
|
N/A | |
| Completed |
NCT00586183 -
Cardiac Sympathetic Activity in Patients With the Apical Ballooning Syndrome
|
N/A | |
| Completed |
NCT01524861 -
Sympathetic Heart Innervation in Patients With Tako-Tsubo Cardiomyopathy
|
Phase 4 |